Home
Live Updates
GLP-1R agonists clinical trial design must be improved to ease concerns : comparemela.com
GLP-1R agonists clinical trial design must be improved to ease concerns
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, have garnered a lot of attention in the pharma industry and beyond.
Related Keywords
Costanza Alciati ,
,
Bio Developments ,
Pipelines ,
Emerging Markets ,
Glp 1 ,
Eli Lilly ,
Novo Nordisk ,
Obesity ,
Clinical Trial ,
comparemela.com © 2020. All Rights Reserved.